Predictmedix Submits Patent Application for Mass Screening for Infectious Diseases

Apr 27, 2020 - Media

Predictmedix (CSE: PMED-OTCQB: PMEDF) CEO Dr Rahul Kushwah joined Steve Darling from Proactive to bring news the company has filed a patent for their game-changing technology for mass screening for infectious disease such as COVID-19. Dr Kushwah discusses how the technology works and why he feels airports, stadiums and other large venues could be a […]

Dr. Rahul Kushwah on How AI Will Revolutionize Impairment Testing

Feb 7, 2020 - Media

CSE’s Barrington Miller was recently joined by Dr. Rahul Kushwah, COO at Cultivar Holdings Inc. (CSE:CULT), to discuss his company’s recent listing on the Canadian Securities Exchange and the innovative work his company is pursuing in the application of artificial intelligence to impairment detection.

Cultivar Holdings Technology Is Game Changer When It Comes to Detecting Impairment

Feb 6, 2020 - Media

Cultivar Holdings (CSE: CULT) Co-Founder and COO Dr Rahul Kushwah joined Steve Darling from Proactive in Toronto to provide details about the technology company working the cannabis space. Dr Kushwah sharing details about their proprietary technology to decipher when someone is impaired on both alcohol and cannabis. Dr Kushwah told Proactive where they are in […]

Canadian Company has Developed Groundbreaking Artificial Intelligence Sobriety Testing for Alcohol/Cannabis Impairment

Jan 20, 2020 - Media

By Craig Patterson January 20, 2020   Toronto-based Cultivar Holdings has launched a new tested artificial intelligence technology (“PredictMedix”) that it says will revolutionize how companies and law enforcement are able to test sobriety by detecting impairment for alcohol and cannabis. The company recently went public and its shares began trading  on the Canadian Securities Exchange (CSE:CULT). Shares […]